FDA Approves Vorasidenib, a New Treatment for Low-Grade Gliomas
A new treatment called vorasidenib has been approved by the U.S. Food and Drug Administration (FDA) for people with low-grade gliomas
Collaboration & Hope: Highlights from the SNO/ASCO Central Nervous System Metastases Conference
The Society for Neuro-Oncology (SNO)/American Society of Clinical Oncology (ASCO) Central Nervous System (CNS) Metastases Conference brought together leading experts, researchers,
My Life-Changing Experience
by Martin Hospina Diagnosed in 2011, with a meningioma that had to be removed surgically. It was too big for radiation
Surviving Glioblastoma: My Journey from Diagnosis to 12 Years Cancer-Free
by Katie Kaiser Smith In 2012, my life was filled with the joys and challenges of raising a one-year-old baby girl
Jean Arzbaecher, RN, MS
Jean Arzbaecher is an advanced practice nurse working as a clinical nurse specialist in neuro-oncology at the University of Illinois Brain
Join Us to Raise Awareness and Funds for GBM Research
Double your impact toward our $50,000 goal to accelerate high-risk, high-reward research during GBM Awareness Day (7/17).
Uncovering New Approaches to Accelerate GBM Treatment
In recognition of GBM Awareness Day, discover two emerging researchers taking novel approaches to overcome obstacles in treating glioblastoma.
Meet Matthew Zachary: Survivor, Patient Advocate, & 2024 National Conference Keynote
From surviving brain cancer at 21 to leading a social movement, Matthew Zachary has dedicated his career to making the cancer experience suck less for adolescents and young adults (AYA) around the world.
Why You Should Make a Will and How to Get Started for Free
Are you among the 70% of Americans who haven’t made a will yet? There’s good news… it’s a lot easier than you may think.
The Importance of Advocacy and Support in AYA Cancer Care
After surviving brain cancer at a young age, Savannah Mason is highlighting the pressing need for tailored advocacy and support resources for AYA cancer patients.
Traveling National Parks After a GBM Diagnosis
After being cleared to hike again after GBM surgery, Darrell and Andrea are back on their quest to see every national park in the country and make the most of each day.
A New Beginning: My Journey Through Brain Cancer
The morning I woke up in my new city of Las Vegas, I felt like I hadn’t slept more than a
Brad’s Journey: A Story of Resilience and Hope
Brad’s journey is an extraordinary one. In October 2022, he began experiencing persistent headaches. Mid-month, due to the smoky and dry
Navigating Life with Glioblastoma: Embracing Anticipatory Grief
Before I learned about “anticipatory grief,” I learned about a brain cancer called Glioblastoma. In 2022, my husband Tom, the love
Wendy Santana, 10 YEARS Brain Tumor-Free After Her Craniotomy
After being medically retired for eight years due to a malignant brain tumor, I decided to meet hope head on by stepping into
Momentum is Building for Meet Hope Head On!
We’re in the midst of Brain Tumor Awareness Month (BTAM) and hope you’re as inspired as we are by the outpouring
Cycling Ahead for Brain Tumor Breakthroughs
For Nicholas “Nick” Cho, an ABTA summer fellowship solidified his interest in becoming a physician-scientist in neuroradiology. Now on track to
Register Now for the Largest Patient and Caregiver Brain Tumor Conference
Registration is now open for the largest educational conference for brain tumor patients and caregivers! Join us Thursday, September 5 –
A Young Adult’s Journey Through Brain Tumor Diagnosis and Recovery: Understanding the Adolescent and Young Adult Patient Experience
This May, the Central Brain Tumor Registry of the United States (CBTRUS) published a groundbreaking report funded by the American Brain
Inspiring Hope: Joe’s Story As A Glioblastoma Survivor
**Sponsored Content**
After facing a GBM recurrence just months after initial treatment, GBM Survivor Joe and his wife Tammy are traveling the country tumor free 18 months after receiving an implantable device that delivers targeted radiation,
Exploring New Frontiers: Y-90 Internal Radiation Trial for Recurrent Glioblastoma
**Sponsored Content**
Learn about an active clinical trial studying Y-90, an internal radiation treatment that aims to directly target brain cancer while minimizing harm to surrounding healthy tissue.
New Statistical Report Reveals Primary Brain and Central Nervous System Tumors as Second Most Common Cancer Type in Adolescents and Young Adults
CHICAGO (May 7, 2024)—Today, the American Brain Tumor Association (ABTA), in partnership with the National Institutes of Health’s National Cancer Institute (NCI) Comprehensive Oncology Network Evaluating Rare CNS Tumors (NCI-CONNECT) program and the Central Brain Tumor Registry of the United States (CBTRUS), unveiled a new report shedding light on the prevalence of primary brain and other central nervous system (CNS) tumors among adolescents and young adults (AYAs) between the ages of 15 and 39.
ABTA President and CEO Ralph A. DeVitto Announces Retirement
Chicago, IL (May 6, 2024)—The American Brain Tumor Association (ABTA) announced that President and CEO Ralph A. DeVitto has informed the Board of Directors of his intention to retire from ABTA in January 2025, after leading the organization for nearly seven years.
A Dual Phase 1/2, Investigator Initiated Study to Determine the Maximum Tolerated Dose, Safety, and Efficacy of 186Rhenium Nanoliposomes (186RNL) in Recurrent Glioma (CTRC# 12-02)
Featured Clinical Study A Dual Phase 1/2, Investigator Initiated Study to Determine the Maximum Tolerated Dose, Safety, and Efficacy of 186Rhenium
Inaugural Year of Meet Hope Head On Yields $10M Investment in Our Mission
Discover how we’re closer to tripling our investment in research thanks to your support of Meet Hope Head On!
Incorporating Diet & Nutrition in Your Brain Tumor Care
Get tips for optimizing what you eat during brain tumor treatment and in recovery.
When Melanoma Metastasizes to the Brain
Explore the risks of melanoma metastasizing to the brain and join an upcoming webinar to empower yourself or a loved one.
Sangami Pugazenthi Awarded 2023 ABTA Lucien Rubinstein Award for ‘Radiation Resistance in Grade 2 Meningiomas’
Sangami Pugazenthi is rewarded for her research exploring biological processes behind radiation resistance in grade 2 meningiomas.
Climbing Higher: Janice Armbrust’s Glioblastoma Journey at Pacific Neuroscience Institute
**Sponsored Content**
There’s no stopping Janice Armbrust. Discover how her passion for hiking is helping her thrive with glioblastoma.
Minimally Invasive Surgery Provides Easier Option For Some Patients
**Sponsored Content**
Discover how Mayo Clinic is leveraging minimally invasive surgical techniques to maximize tumor resection while making recovery easier for patients.
American Brain Tumor Association Announces New Board of Directors Officers and Members
Meet the ABTA’s newest Board Members, Laura Aguilar, MD, PhD, and Charles (Chad) Schafer, JD.
Annual SNO Meeting Fosters Unprecedented Collaboration
Read our top takeaways from the Society for Neuro-Oncology (SNO) Annual Meeting, the world’s largest gathering of neuro-oncology experts.
Bri’s Journey to Living Life ‘By Design’
Discover how a brain tumor diagnosis led Bri to live a more fulfilling life and how she’s helping others do the same.
Connect with Your Community in 2024
A new year brings new opportunities to make a difference in the brain tumor community and empower yourself!
Clinical Trial Testing Effectiveness of Blood Cancer Drug in Recurrent Glioblastoma
**Sponsored Content**
Learn more about Biodexa’s Phase 1 clinical trial investigating the effectiveness of an approved blood cancer drug in liquid form to treat recurrent glioblastoma (GBM).
Study to Evaluate the Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBl-1901 in Recurrent GBM Subjects
Study to Evaluate the Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBl-1901 in Recurrent GBM Subjects Featured Clinical Study
A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM (FRONTIER)
Featured Clinical Study A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM
Your Support Turns Hope Into Action
Join us in our mission to accelerate research breakthroughs and fuel hope for brain tumor patients and families.
Six Tips From My Experience As a Caregiver
For National Family Caregivers Month, Robin Ferrill shares tips from her experience embracing the role after her husband’s GBM diagnosis in 2022.
Brain Tumor Survivor Shares Top Three National Conference Takeaways
After losing her husband to GBM in 2022 and receiving her own diagnosis, survivor Beth Kassab didn’t know what to expect attending the largest brain tumor conference in Chicago. Read Beth’s top takeaways:
Don & Gail Segal Awarded Top Honor for Their Life-long Commitment to the ABTA
Discover how one couple’s efforts to make a difference after their young son was diagnosed with a brain tumor led to their vital role in establishing the ABTA and ensuring its ongoing success.
Sally Walker Honored for Dedication to Daughter’s Legacy, Advancing Research
After losing her daughter Kristi to GBM in 2011, Sally set out to carry on her daughter’s legacy of living life to the fullest and supporting brain tumor research.
Imvax Advances a New Approach to Personalized Cancer Immunotherapy
**Sponsored Content**
Learn more about Imvax’s Phase 2b trial studying a personalized, whole tumor-derived immunotherapy in newly diagnosed patients with glioblastoma.
Meet ABTA’s Eight Newest Summer Research Fellows
The ABTA is proud to announce eight recipients of the Medical Student Summer Fellowship grants.
Join a Brain Tumor 5k Run & Walk Near You this Fall
You can make a difference and raise critical funds for research by joining a Breakthrough for Brain Tumors 5k Run & Walk event.
Three Reasons Acoustic Neuroma Patients Need a Multidisciplinary Care Team
**Sponsored Content**
An acoustic neuroma diagnosis comes with complex treatment decisions. Read why a multidisciplinary care team is crucial for your long-term recovery.
All in the Family: Raising Awareness and Support for GBM Research
Join us July 19 to raise $50K for GBM research.
Your Long-Time Brain Tumor Champion Ups Its Game in Washington
With the reigniting of the White House’s Cancer Moonshot Initiative, the ABTA recently joined the Brain Cancers Forum in Washington, D.C., to discuss opportunities in discovering treatments for brain cancers, including GBM.
Author, Podcaster Bryan Bishop Named 2023 National Conference Keynote Speaker
Author, podcaster, and brain tumor survivor Bryan Bishop will take the stage as keynote of the 2023 ABTA National Conference. Discover how humor has carried Bryan through his 14-year battle.
First Targeted Therapy for Glioma Headed for FDA Approval
A first-in-class targeted therapy for low-grade glioma could gain FDA approval as early as spring 2024. Here are three things you should know about the emerging drug “vorasidenib.”
Coping with a GBM Diagnosis: Developing a Routine
**Sponsored Content**
After processing the initial shock of her GBM diagnosis at 36, Jeanneane M. created a “coping routine” that’s helped her get through difficult days and hold onto hope for her future.
Robert Johnson
I Meet Hope Head On by sharing my story and being a mentor for the ABTA. The first 10 years after
Pam F., Pennsylvania
I met hope head on by taking care of my dad. My dad was diagnosed with GBM in Dec. 2014. The
Rose V., Wisconsin
I meet hope head on by carrying on my husband Christian’s memory and knowing that his brain cancer journey, though difficult
Jessie S., Illinois
I Meet Hope Head On by advocating for more research breakthroughs and medical innovations that helped my dad survive 40 years
Dawn F., Florida
I Meet Hope Head On by going to the eye doctor for a basic checkup. My older sister is driving me
“Doing Hard Things” Community Bands Together to Drive Kelli McLaughlin’s Legacy Forward
Family and friends of Kelli McLaughlin are doing the hardest things: turning their grief into action to carry on Kelli’s legacy and vision of a future without brain tumors.
Together, Let’s Meet Hope Head On
Discover how you can play a role in the ABTA’s five-year campaign “Meet Hope Head On.”
Taking Control of Your Brain Metastases Care
Join a free, half-day virtual meeting for patients and families dealing with brain metastases, led by Priya Kumthekar, MD, Director of the Brain Metastases Program at Northwestern University.
2023 ABTA National Conference Returns To Chicago
Register now for the nation’s largest patient-centric brain tumor conference, returning to Chicago and online this September.
Neurosurgeon Brings One-of-a-Kind Imaging Technology to Puerto Rico to Advance Brain Tumor Surgery
**Sponsored Content** Meet one neurosurgeon who hopes to transform brain tumor care by bringing state-of-the-art technology to his homeland of Puerto Rico.
Unite & Make a Difference at a BT5K
Gather friends and family to raise awareness and critical funds at a BT5K Run & Walk event near you.
What You Should Know About Clinical Trials for Brain Tumors
**Sponsored Content** Advancements in brain tumor treatments are made possible by patients who volunteer to participate in clinical trials.
Still Pursuing Answers
ABTA Founder Susan Kramer reflects on the last 50 years and her unrelenting pursuit toward finding a cure.
From One to Many
We need 500 people to donate or share their story for the ABTA’s first Day of Giving during Brain Tumor Awareness Month. Are you in?
Igniting Hope at the National Conference
See what’s igniting hope at the nation’s largest brain tumor conference and how you can get involved.
David Hou Awarded 2022 ABTA Lucien Rubinstein Award for ‘B Cell Vaccine Promotes Anti-Glioma Immunity Through Modulating CD8+ T Cells’
David Hou is awarded for his research on leveraging a B cell vaccine to improve immunotherapy treatment for GBM.
A Targeted Solution in Glioblastoma Treatment
**Sponsored Content**
For adult patients with recurrent GBM, a new clinical trial may offer access to emerging solutions and novel therapies unavailable elsewhere.
American Brain Tumor Association Announces New Board of Directors Chair, Officers and Member
Meet the newly-appointed ABTA Board Chair and Member and discover what they’re hopeful for in their new roles.
A Dose Escalation and Expansion Study of Sonodynamic Therapy With SONALA-001 in Combination With Exablate 4000 Type-2 MR-guided Focused Ultrasound in Patients With Recurrent or Progressive Glioblastoma Multiforme
Featured Clinical Study A Dose Escalation and Expansion Study of Sonodynamic Therapy With SONALA-001 in Combination With Exablate 4000 Type-2 MR-guided
Research Update: DCVax-L Phase 3 Clinical Trial Data Published for GBM
On November 17, 2022, results from a phase 3 trial of DCVax-L, an immunotherapy for glioblastoma patients, were published in the Journal of the American Medical Association (JAMA) Oncology.
Answering the Top Three CareLine Questions
Vince Rock answers the top questions he receives from patients and caregivers who call the ABTA CareLine.
Processing Our Brain Cancer Journey Through Song
In his own words, caregiver and musician Scott Ingersoll shares how he used music to channel his wife’s journey battling astrocytoma.
2023: We’re Better Together
As we welcome 2023, it’s a time to embrace the new year and new ways to get involved and make an impact in the brain tumor community.
Study of Tirabrutinib (ONO-4059) in Patients With Primary Central Nervous System Lymphoma (PROSPECT Study)
Study of Tirabrutinib (ONO-4059) in Patients With Primary Central Nervous System Lymphoma (PROSPECT Study).
American Brain Tumor Association Partners with Brain Tumour Foundation of Canada on Low-Grade Glioma Research
The American Brain Tumor Association (ABTA) today announced a new partnership with Brain Tumour Foundation of Canada (BTFC) to accelerate brain tumor research. Through this partnership, BTFC will invest in the ABTA research program to co-fund a research project in Canada, focused on improving resection for low-grade glioma.
American Brain Tumor Association Awards 20 Research Grants to Advance Brain Tumor Science and Discoveries
The American Brain Tumor Association (ABTA) today announced the funding of $821,000 towards 20 new research grants to advance brain tumor science and treatments. With more than $34 million invested in research to date, across all brain tumor types and ages, the ABTA research program plays a critical role in advancing the understanding of brain tumors and building the next generation of brain tumor researchers.
Harnessing Hope for Treatment Breakthroughs
Meet two researchers on opposite ends of the globe dedicated to transforming the future of brain tumor treatments.
Five Tips to Enhance Caregiver Well-being
November is National Family Caregivers Month. Jamie Jacobs, PhD, of Massachusetts General Hospital shares five tips to enhance caregiver well-being.
Clinical Advances in GBM
**Sponsored Content**
See how a cutting-edge imaging solution by Medexus Pharma is revolutionizing treatment outcomes for GBM patients.
Shanu Khanuja, MPH, BA
Shanu Khanuja currently works within the biotech industry and serves in commercial roles that continue to bring to light the patient
Robin Page, Cancer Patient Advocate
Robin Page is a cancer patient advocate. She currently works as a physical therapist and the director of The Core Life
Justin’s Walk Celebrates 25 Years
A small Virginia community celebrates 25 years of coming together for Justin Porter, a six-year-old who passed away from GBM.
Top Takeaways from the 2022 National Conference
From innovations in brain surgery to tips for living your best life, get the top takeaways from the 2022 National Conference.
Inspiring Hope: Meet the 2022 ABTA Award Recipients
Meet the recipients of the ABTA’s highest honors and learn how they’re making a difference.
This Fall, Get Involved Through A BT5K
This fall, join the brain tumor community for a BT5K Run & Walk and raise crucial funds for research!
Pacific Neuroscience Institute’s Top Brain Surgeons Attract Patients from Around the World
**Sponsored Content**
Chris traveled across the country for a minimally invasive “keyhole” procedure to remove his large meningioma. Read why he chose Dr. Daniel Kelly at Pacific Neuroscience Institute (PNI) for his brain surgery.
Living with Brain Metastases from Lung Cancer
Did you know 25% of lung cancer patients develop brain metastases? Get a look at the facts ahead of Lung Cancer Awareness Month.
Support Research Breakthroughs on GBM Awareness Day
You probably already know that GBM is a vicious, deadly disease. The question we all have is, what are we going to do about it? As we approach the fourth annual GBM Awareness Day on July 20, 2022, we’re asking you to get involved.
Behind the Scenes: Q&A with National Conference Co-Chairs
Go behind the scenes of the nation’s largest brain tumor conference and hear why the co-chairs say you don’t want to miss this year’s event, Sept. 9-10!
Highlights and Hope for the Future of GBM Research
Dr. Duane Mitchell, MD, PhD, Univ. of Florida, shares four highlights in recent GBM research and what he’s hopeful for in the future.
Beyond Par: 25 Years of Celebrating Paul Fabbri’s Legacy & Supporting Brain Tumor Research
What started as a small golf outing to remember a beloved friend lost to brain cancer has blossomed into 25 years of a shining legacy and more than $660,000 for crucial brain tumor research.
From Testing to Treatment: What to Know About Targeted Therapies
**Sponsored Content**
Referred to as the “center point of progress in modern oncology,” biomarker testing opens up a world of targeted therapies that can guide an oncology treatment plan and turn more patients into survivors.
What You Should Know from AACR
Read three takeaways from the American Association for Cancer Research annual meeting in April.
Beyond the Odds: Mary’s Story Surviving Glioblastoma
**Sponsored Content**
See how Mary is defying the odds years after her initial glioblastoma diagnosis and how she found peace of mind through GammaTile Therapy, a one-time, targeted radiation treatment.
Learn | Engage | Connect: Register for 2022 Conference
Engage with your community and learn about the latest treatment advances at the ABTA National Conference, September 9-10.
Five Things to Do If You or a Loved One is Diagnosed with a Brain Tumor
Dr. Gabriel Zada, a leading neurosurgeon at USC, shares five things you can do after receiving a brain tumor diagnosis.
Living with GBM and Adventure
**Sponsored Content**
After Craig was diagnosed with a glioblastoma in May of 2018, he decided he would not let it stop his active lifestyle. Through patience and some small adjustments, he continues to do the activities he loves.
Lacing Up for the Return of In-Person BT5K’s
Meet three BT5K team leaders from different states who are gearing up to be back in person with their local brain tumor communities. Learn how you can get involved this year.
New Webinar ‘How Metastatic Brain Tumors Affect Your Breast Cancer Care’ Increases Awareness of Brain Metastasis Risks and Treatment Options
An upcoming webinar, presented in partnership with Living Beyond Breast Cancer, builds awareness of brain metastasis risks and treatment options for breast cancer patients.
